Almi Invest is a Swedish venture capital firm established in 2009, focusing on investing in promising start-ups with scalable business models and committed entrepreneurs. The firm operates through seven regionally based funds, each managed by experienced local investment professionals. With a total capital of SEK 1 billion, Almi Invest typically makes initial investments ranging from SEK 2 to 4 million, with the potential to extend up to SEK 10 million during the investment's lifecycle. The firm emphasizes collaboration by syndicating investments with other venture capitalists or angel investors, allowing it to acquire a maximum of 50 percent of shares in any given funding round. Almi Invest sources its capital from European Union structural funds and regional investors, with half of its funding derived from each. The firm's structure as an Evergreen Fund allows it to reinvest generated returns, contributing to its ongoing investment capacity. Additionally, the Almi Invest GreenTech Fund targets early-stage investments in clean tech, climate tech, and life sciences, aiming for a diverse portfolio through at least 50 investments.
EmbeDL operates as a software company. EmbedlOpt Research and Technology AB is a spin-off from a collaborative research project on low energy computing.
Alertix Veterinary Diagnostics AB provides is a biotechnology company engages in development and research of in vitro assays, serums, and biomarkers for early detection and monitoring of cancer diseases in dogs, cats and horses. It offers Alertix Canine, an immunodiagnostic assay for measuring the presence of the enzyme thymidine kinase (TK1) in blood from dogs; Alertix immunodiagnostic assay for cat TK1; and Alertix immunodiagnostic assay for horse TK1. It also provides cancer detection and testing services. Alertix Veterinary Diagnostics AB was founded in 2017 and is headquartered in Kalmar, Sweden.